TreeFrog Therapeutics
cell therapy pipeline

World first

Mature neuron graft to treat Parkinson’s disease in 2018

High-quality

iPSCs produced with c-GMP compatible C-Stem™ platform

Controlled differentiation

Stem cells are amplified and differentiated homogeneously within 3D capsules

iPSC-based cell therapies
Discovery
Preclinical
Clinical

Huntington / Parkinson’s Disease Stem Cell Therapy

brain

Funded by ANR & i-LAB

Heart Failure Stem Cell Therapy

heart failure cell therapy

Diabetes Stem Cell Therapy

pancreas

NASH Stem Cell Therapy

liver

AMD Stem Cell Therapy

retina

Traumatic injury Stem Cell Therapy

cartilage

Skin burns / Dermatitis Stem Cell Therapy

skin

iPSC-based cell therapies

Preclinical

Huntington / Parkinson’s Disease Stem Cell Therapy

brain

Funded by ANR & i-LAB

Discovery

Heart Failure Stem Cell Therapy

heart failure cell therapy

Diabetes Stem Cell Therapy

pancreas

NASH Stem Cell Therapy

liver

AMD Stem Cell Therapy

retina

Traumatic injury Stem Cell Therapy

cartilage

Skin burns / Dermatitis Stem Cell Therapy

skin

Work with us

Co-development & licensing opportunities

MAXIME FEYEUX

Maxime Feyeux, PhD

Contact our CSO